MED COVID-19: Understanding AD/ADRD brain changes after COVID-19 (Milestone 2.CC)
In Progress
Timeline Start - End
2022 - 2029Research Implementation Area
Research on Disease MechanismsAD-Related Dementias Focus
Advance understanding of basic mechanisms underlying neurocognitive impairment and dementia due to COVID-19 in order to develop biomarkers, risk profiles, and the foundation for early interventional trials.
Success Criteria
- At least three studies to determine basic mechanisms, potential biomarkers, and pathways with potential for therapeutic intervention, underlying increased risk of long-term cognitive impairment and dementia outcomes following COVID-19.
Summary of Key Accomplishments
This milestone has just been initiated. Accomplishments are forthcoming.
The key accomplishments summary is current as of November 2022.